NeoGenomics, Inc.
NEONASDAQ
Healthcare
Medical - Diagnostics & Research
$7.97
+0.23(2.9%)
52W $4.84 – $13.22
NeoGenomics, Inc.
Revenue breakdown: Client Direct Billing (71.9%), Commercial Insurance (15.4%), Medicare And Other Governmental (12.6%).
$207MMkt Cap
$734MRev TTM
-$109MNI TTM
-1.9xP/E TTM
Latest Earnings
10-K
FY FY2025Feb 16, 2026NeoGenomics, Inc. reported a net loss of $108.0 million for fiscal year 2025, driven by a loss from operations of $115.9 million despite generating $727.3 million in revenue. The company's gross margin was $314.3 million, representing a 43.2% gross margin rate. Operating expenses totaled $430.2 million, including significant impairment charges of $27.8 million. Cash flow from operations was positive at...
What Changed Recently
Fundamentals
How The Business Makes Money
Revenue by Segment
Client Direct Billing71.9%
Commercial Insurance15.4%
Medicare And Other Governmental12.6%
Self Pay Services0.1%
Company Profile
CIK0001077183
ISINUS64049M2098
CUSIP64049M209
Phone239 768 0600
Address9490 NeoGenomics Way, Fort Myers, FL, 33912, US
SEC EDGAR